- SCENIC TrialRandomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study with Inhaled RVT-1601 for the Treatment of Persistent Cough in Patients with Idiopathic Pulmonary Fibrosis (IPF).Trial Age Group: Over 18 years Trial Disease Type: Interstitial Lung Disease (ILD) Trial Participant Type: Patient Trial Phase: Not applicable Trial Location: NSW Trial Status: Discontinued Trial Type: Interventional
- SPIRITA Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BG00011 in Patients With Idiopathic Pulmonary Fibrosis (IPF)Trial Age Group: Over 18 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Not applicable Trial Location: VIC Trial Status: Discontinued Trial Type: Interventional
- Blade TherapeuticsA Phase 1a/1b, Randomized, Double Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BLD-2660 in Healthy Volunteers and Subjects with Lung Fibrosis or Liver FibrosisTrial Age Group: Over 18 years Trial Disease Type: Pulmonary Fibrosis (PF) Trial Participant Type: Patient Trial Location: NSW Trial Status: Discontinued Trial Type: Interventional
- Isabela 1&2A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Two Doses of GLPG1690 in Addition to Local Standard of Care for Minimum 52 Weeks in Subjects With ldiopathic Pulmonary Fibrosis,Trial Status: Discontinued